Melinda Hatton
Melinda Hatton
Giulia Jannone,Marie-Astrid van Dievoet,Louise Coppin et al.
Giulia Jannone et al.
Regulatory and Legislative Disparities With Cannabis Present Challenges to P&T Committees and Health Care Providers [0.03%]
法规和立法差异给药事委员会和医疗保健提供者使用大麻带来挑战
Rita Marcoux,Lauren Holmes,F Randy Vogenberg et al.
Rita Marcoux et al.
Increased cannabis use has brought about a sea change in policy and attitudes toward regulation, and a multitude of rules that vary widely between states. The disparity has stymied any effective response to the problems surrounding access t...
Reframing Alzheimer's Disease: Guided by a New Research Framework, the Field is Poised For Greater Precision and Promising Horizons [0.03%]
重构阿尔茨海默病研究体系：新研究框架引领精准医学和展望未来_horizon杂谈
Susan L Worley
Susan L Worley
This in-depth article on the sixth leading cause of death in the U.S. reports on the optimism of cutting-edge leaders in Alzheimer's disease research. The author examines key considerations such as the status of biomarker tests, and the sea...
Walter Alexander
Walter Alexander
We report on two sessions on atrial fibrillation, two on heart failure, two on hypertension, and one each on endocarditis and ST-elevation myocardial infarction.
Virtual Reality in Pharmacy: Opportunities for Clinical, Research, and Educational Applications [0.03%]
虚拟现实与药学：临床、科研及教育应用的机会
C Lee Ventola
C Lee Ventola
Virtual reality (VR) has been widely studied and applied in numerous medical applications.1 In pharmacy, VR can potentially be applied as follows: adjunctively or as a replacement for pharmacotherapy; in drug design and discovery; in pharma...
Are Hospital Prices a Bigger Problem than Drug Prices?: Congress Doesn't Know, Doesn't Care [0.03%]
医院收费比药价更严重吗？国会不知道也不关心
Stephen Barlas
Stephen Barlas
What lies behind the growth of rising hospital prices? Many factors-including the impact of hospital mergers and the industry's complicated relationship with Congress.
Treatment of Seizures Associated with Lennox-Gastaut and Dravet Syndromes: A Focus on Cannabidiol Oral Solution [0.03%]
用于治疗Lennox-Gastaut综合征和Dravet综合征相关性癫痫发作的Cannabidiol口服溶液疗法
Dovena Lazaridis,Nathaniel Eraikhuemen,Kia Williams et al.
Dovena Lazaridis et al.
Cannabidiol oral solution for seizures associated with Lennox-Gastaut and Dravet syndromes.
Pharmaceutical Approval Update [0.03%]
医药审批更新
Michele B Kaufman
Michele B Kaufman
Cablivi (caplacizumab-yhdp) for acquired thrombotic thrombocytopenic purpura; Egaten (triclabendazole) for fascioliasis; and Spravato (esketamine) for treatment-resistant depression.